A comparison of the efficacy of piperacillin-tazobactam and cefoperazone-sulbactam therapies in the empirical treatment of patients with febrile neutropenia. Aynioglu A et al. Rev Esp Quimioter. 2016 Feb 16. pii: aynur16feb2016. [Epub ahead of print]. Retained needle after cement injection during vertebral augmentation and its management strategy. Kosse A et al. BMJ Case Rep. 2016 Feb 18;2016. pii: bcr2015012180. doi: 10.1136/bcr-2015-012180.…
Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy. Wang J et al. Support Care Cancer. 2016 Feb 23. [Epub ahead of print]. Early Postoperative Outcomes After Total Joint Arthroplasty in Patients With Multiple Myeloma. Menendez ME et al. J Arthroplasty. 2016 Jan 29. pii: S0883-5403(16)00091-7. doi:10.1016/j.arth.2016.01.029. [Epub ahead of print]. Bortezomib-based…
A phase 2 study of three low-dose intensity subcutaneous Bortezomib regimens in elderly frail patients with untreated multiple myeloma. Larocca A et al. Leukemia. 2016 Feb 22. doi: 10.1038/leu.2016.36. [Epub ahead of print]. A single-center retrospective analysis of first-line therapy of multiple myeloma with bendamustine-bortezomib-dexamethasone. Zwickl H et al. Leuk Lymphoma. 2016 Feb 22:1-6. [Epub ahead of print]. Stem Cell Harvesting after Bortezomib-Based Reinduction…
The National Institute of Health and Care Excellence (NICE) has set out new guidance for the diagnosis, treatment and care of myeloma patients with the aim of providing consistently excellent patient-focused care within NHS England. The new guidance has been created to cover aspects of management where in the past there was uncertainty or variation…
Multiple Myeloma: Diagnosis and Treatment. Rajkumar SV et al. Mayo Clin Proc. 2016 Jan;91(1):101-19. doi: 10.1016/j.mayocp.2015.11.007. Management of relapsed multiple myeloma: Recommendations of the international myeloma working group. Laubach J et al. Leukemia. 2015 Dec 29. doi: 10.1038/leu.2015.356. [Epub ahead of print]. First hematopoietic cell transplantation in Uzbekistan: Progress through education and cooperation. Karimov K et al. Transfus Apher Sci. 2016 Jan 12. pii: S1473-0502(16)00016-1. doi: 10.1016/j.transci.2016.01.014.…
Comparison of unilateral versus bilateral percutaneous kyphoplasty for the treatment of patients with osteoporosis vertebral compression fracture (OVCF): a systematic review and meta-analysis. Cheng X et al. Eur Spine J. 2016 Jan 27. [Epub ahead of print]. Pathophysiology of Metastatic Bone Disease and the Role of the Second Generation of Bisphosphonates:From Basic Science to Medicine. Barghash RF et…
Retrospective study of the incidence and patterns of arterial and venous thrombosis in Chinese versus African American patients with multiple myeloma. Raghupathy R et al. Br J Haematol. 2016 Jan 26. doi: 10.1111/bjh.13942. [Epub ahead of print]. Adventitious sporulation in Fusarium: The yeast that were not. Lockwood MB et al. IDCases. 2015 Dec 17;3:5-7. doi: 10.1016/j.idcr.2015.10.004. eCollection 2016. Bone Disease in Myeloma: The…
Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma. Magarotto V et al. Blood. 2016 Jan 4. pii: blood-2015-08-662627. [Epub ahead of print]. Lenalidomide plus melphalan and prednisone, followed by lenalidomide maintenance versus thalidomide plus melphalan and prednisone, followed by thalidomide maintenance; results of the randomised phase 3 HOVON 87/NMSG18 trial.…
Percutaneous vertebroplasty for patients with metastatic compression fractures of the thoracolumbar spine: clinical and radiological factors affecting functional outcomes. Bae JW et al. Spine J. 2015 Dec 2. pii: S1529-9430(15)01694-0. doi: 10.1016/j.spinee.2015.11.033. [Epub ahead of print]. Bone Marker-Directed Dosing of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Multiple Myeloma: Results of the Z-MARK Study.…
Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation. Ahmad I et al. Bone Marrow Transplant. 2015 Dec 21. doi: 10.1038/bmt.2015.319. [Epub ahead of print]. Phase I/II trial of Weekly Bortezomib with Lenalidomide and Dexamethasone in First Relapse or Primary Refractory Myeloma. Broijl A et al. Haematologica. 2015 Dec 11. pii: haematol.2015.132431. [Epub ahead…